INS and Insulin resistance: These researchers, however, did not find that estradiol improved insulin resistance; after 6 months administering 25 μg of transdermal estradiol (Estraderm TTS, Novartis) twice a week, the fasting insulin level was 2.66 times higher than at the beginning of the study [27,28].